[1]
|
Nutman, A., Glick, R., Temkin, E., Hoshen, M., Edgar, R., Braun, T., et al. (2014) A Case-Control Study to Identify Predictors of 14-Day Mortality Following Car-Bapenem-Resistant Acinetobacter baumannii Bacteremia. Clinical Microbiology and Infection, 20, O1028-O1034. https://doi.org/10.1111/1469-0691.12716
|
[2]
|
Chagas, T.P.G. (2015) Characterization of Acinetobacter spp. Multirresistentes Produtores de carbapenemases, do tipo OXA e NDM, isolados de diferentes regiões do Brasil. Ph.D. Thesis, Fiocruz, Brasil. https://www.arca.fiocruz.br/bitstream/icict/23208/2/thiago_chagas_ioc_dout_2015.pdf
|
[3]
|
Ayoub Moubareck, C. and Hammoudi Halat, D. (2020) Insights into Acinetobacter bau mannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen. Antibiotics, 9, Article No. 119. https://doi.org/10.3390/antibiotics9030119 https://www.mdpi.com/2079-6382/9/3/119
|
[4]
|
BRASIL (2018) National Action Plan for The Prevention and Control of Antimicrobial Resistance in the Scope of Single Health 2018-2022. https://portalarquivos2.saude.gov.br/images/pdf/2018/dezembro/20/af-pan-br-17dez18-20x28-csa.pdf
|
[5]
|
Lukovic, B., Gajic, I., Dimkic, I., Kekic, D., Zornic, S., Pozder, T., et al. (2020) The First Nationwide Multicenter Study of Acinetobacter baumannii Recovered in Serbia: Emergence of OXA-72, OXA-23 and NDM-1-Producing Isolates. Antimicrobial Resistance & Infection Control, 9, Article No. 101. https://doi.org/10.1186/s13756-020-00769-8
|
[6]
|
Neves, F.C., Clemente, W.T., Lincopan, N., Paião, I.D., Neves, P.R., Romanelli, R.M., et al. (2016) Clinical and Microbiological Characteristics of OXA-23- and OXA-143-Producing Acinetobacter baumannii in ICU Patients at a Teaching Hospital, Brazil. The Brazilian Journal of Infectious Diseases, 20, 556-563. https://doi.org/10.1016/j.bjid.2016.08.004
|
[7]
|
de Azevedo, F.K.S.F., Dutra, V., Nakazato, L., Pepato, M.A., de Sousa, A.T.H.I., de Azevedo, C.C.S.F., et al. (2019) New Sequence Types of Acinetobacter baumannii in Two Emergency Hospitals in the Central-West Region of Brazil. Revista da Sociedade Brasileira de Medicina Tropical, 52, Article ID: e0176790. https://doi.org/10.1590/0037-8682-0077-2019
|
[8]
|
Castilho, S.R.A., de Godoy, C.S.M., Guilarde, A.O., Cardoso, J.L., André, M.C.P., Junqueira-Kipnis, A.P., et al. (2017) Acinetobacter baumannii Strains Isolated from Patients in Intensive Care Units in Goiania, Brazil: Molecular and Drug Susceptibility Profiles. PLoS ONE, 12, Article ID: e0176790. https://doi.org/10.1371/journal.pone.0176790
|
[9]
|
PARANá (Estado) (2018) Boletim Informativo Avaliação dos Indicadores Estaduais das Infecções Relacionadas à Assistência à Saúde, Resistência Microbianae Consumo de Antimicrobianos no Paraná, notificados no Sistema Online de Notificação de Infecções Hospitalares (SONIH) de janeiro a junho de 2018. https://www.saude.pr.gov.br/sites/default/arquivos_restritos/files/documento/2021-02/boletimsonih_jan_jul_2018.pdf
|
[10]
|
PARANá (Estado) (2019) Boletim SONIH: Boletim Epidemiologico das IRAS. https://www.saude.pr.gov.br/sites/default/arquivos_restritos/files/documento/2021-02/boletim_sonih_resumido_15_05_2020.pdf
|
[11]
|
PARANá (Estado) (2020) Boletim SONIH: Boletim Epidemiologico das IRAS. https://www.saude.pr.gov.br/sites/default/arquivos_restritos/files/documento/2021-06/boletim_informativo_-_sonih_2020_-_versao_final_ceciss-pr.pdf
|
[12]
|
Vandresen, D.F., Lucio, L.C., Yamada, R.S., Vieira, A.P., Follador, F.A.C., Benedetti, V.P., et al. (2021) Associated Factors of Acinetobacter baumannii Complex in Hospitalized Patients: A Case-Control Study. The Journal of Infection in Developing Countries, 15, 73-80. https://doi.org/10.3855/jidc.13525
|
[13]
|
CLSI (Clinical & Laboratory Standards Institute) (2018) M100-Performance Standards for Antimicrobial Susceptibility Testing. 28th Edition, Clinical & Laboratory Standards Institute, Wayne, PA, USA. https://clsi.org/media/1930/m100ed28_sample.pdf
|
[14]
|
EUCAST (European Committee on Antimicrobial Susceptibility Testing) (2018, July 15) Information or NACs—Redefining Antimicrobial Susceptibility Testing Categories. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Consultation/2018/Information_for_NACs_-_Redefining_antimicrobial_susceptibility_testing_categories.pdf
|
[15]
|
PARANá (Estado) (2010) SESA Resolução No. 0674/2010: Aprova o regulamento técnico que estabelece as ações de vigilancia em saúde a serem desenvolvi das no Controle das Bactérias Multirresistentes (BMR) e Bactérias oriundas de Infecções Hospitalares e de Surtos em Serviços de Saúde. https://www.saude.pr.gov.br/sites/default/arquivos_restritos/files/documento/2020-04/resolucao6742010.pdf
|
[16]
|
PARANá (Estado) (2018) Resolução SESA No. 096/2018 Estabelece as ações de vigilancia em saúde a serem desenvolvidas no controle de Microrganismos Multirresistentes (MMR) e Surtos decorrentes de Infecções Relacionadas à Assistência à Saúde (IRAS) em Estabelecimentos de Assistência à Saúde (EAS) no Paraná. https://www.saude.pr.gov.br/sites/default/arquivos_restritos/files/documento/2020-04/96_18.pdf
|
[17]
|
Chusri, S., Chongsuvivatwong, V., Silpapojakul, K., Singkhamanan, K., Hortiwakul, T., Charernmak, B., et al. (2019) Clinical Characteristics and Outcomes of Community and Hospital-Acquired Acinetobacter baumannii Bacteremia. Journal of Microbiology, Immunology, and Infection, 52, 796-806. https://doi.org/10.1016/j.jmii.2019.03.004
|
[18]
|
Ayobami, O., Willrich, N., Harder, T., Okeke, I.N., Eckmanns, T. and Markwart, R. (2019) The Incidence and Prevalence of Hospital-Acquired (Carbapenem-Resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: A Systematic Review and Meta-Analysis. Emerging Microbes & Infections, 8, 1747-1759. https://doi.org/10.1080/22221751.2019.1698273
|
[19]
|
Bento Talizin, T., Dantas de Maio Carrilho, C.M., Magalhães Carvalho Grion, C., Tibery Queiroz Cardoso, L., Toshiyuki Tanita, M., Boll, K.M., et al. (2020) Polymyxin for Treatment of Ventilator-Associated Pneumonia in a Setting of High Carbapenem Resistance. PLoS ONE, 15, Article ID: e0237880. https://doi.org/10.1371/journal.pone.0237880
|
[20]
|
da Silva, K.E., Maciel, W.G., Croda, J., Cayô, R., Ramos, A.C., de Sales, R.O., et al. (2018) A High Mortality Rate Associated with Multidrug-Resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian Intensive Care Unit. PLoS ONE, 13, Article ID: e0209367. https://doi.org/10.1371/journal.pone.0209367
|
[21]
|
Kostyanev, T., Vilken, T., Lammens, C., Timbermont, L., Van’t Veen, A. and Goossens H. (2019) Detection and Prevalence of Carbapenem-Resistant Gram-Negative Bacteria among European Laboratories in the COMBACTE Network: A COMBACTE LAB-Net Survey. International Journal of Antimicrobial Agents, 53, 268-274. https://doi.org/10.1016/j.ijantimicag.2018.10.013
|
[22]
|
Labarca, J.A., Salles, M.J.C., Seas, C. and Guzmán-Blanco, M. (2016) Carbapenem Resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the Nosocomial Setting in Latin America. Critical Reviews in Microbiology, 42, 276-292. https://doi.org/10.3109/1040841X.2014.940494
|
[23]
|
Sader, H.S., Streit, J.M., Carvalhaes, C.G., Huband, M.D., Shortridge, D., Mendes, R.E., et al. (2021) Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria Isolated from Respiratory Samples of Patients Hospitalized with Pneumonia in Western Europe, Eastern Europe, and the USA: Results from the SENTRY Antimicrobial Surveillance Program (2016-19). JAC-Antimicrobial Resistance, 3, Article No. dlab117. https://doi.org/10.1093/jacamr/dlab117
|
[24]
|
Said, D., Willrich, N., Ayobami, O., Noll, I., Eckmanns, T. and Markwart R. (2021) The Epidemiology of Carbapenem Resistance in Acinetobacter baumannii Complex in Germany (2014-2018): An Analysis of Data from the National Antimicrobial Resistance Surveillance System. Antimicrobial Resistance & Infection Control, 10, Article No. 45. https://doi.org/10.1186/s13756-021-00909-8
|
[25]
|
Moghnieh, R., Araj, G.F., Awad, L., Daoud, Z., Mokhbat, J.E., Jisr, T., et al. (2019) A Compilation of Antimicrobial Susceptibility Data from a Network of 13 Lebanese Hospitals Reflecting the National Situation during 2015-2016. Antimicrobial Resistance & Infection Control, 8, Article No. 41. https://doi.org/10.1186/s13756-019-0487-5
|
[26]
|
Li, S., Li, H., Qi, T., Yan, X., Wang, B., Guan, J., et al. (2017) Comparative Transcriptomics Analyses of the Different Growth States of Multidrug-Resistant Acinetobacter baumannii. Biomedicine & Pharmacotherapy, 85, 564-574. https://doi.org/10.1016/j.biopha.2016.11.065
|
[27]
|
Balkhy, H.H., El-Saed, A., Alshamrani, M.M., Alsaedi, A., Al Nasser, W., El Gammal, A., et al. (2020) Ten-Year Resistance Trends in Pathogens Causing Healthcare-Associated Infections; Reflection of Infection Control Interventions at a Multi-Hospital Healthcare System in Saudi Arabia, 2007-2016. Antimicrobial Resistance & Infection Control, 9, Article No. 21. https://doi.org/10.1186/s13756-020-0678-0
|
[28]
|
Towner, K.J. (2009) Acinetobacter: An Old Friend, but a New Enemy. Journal of Hospital Infection, 73, 355-363. https://doi.org/10.1016/j.jhin.2009.03.032
|
[29]
|
Mota, F.S., Oliveira, H.A. and Souto, R.C.F. (2018) Perfil e prevalência de resistência aos antimicrobianos de bactérias gram-negativas isoladas de pacientes de uma unidade de terapia intensiva. RBAC Magazine, 50, 270-277.
|
[30]
|
Agência Nacional de Vigilancia Sanitária (2017) Investigação e controle de bactérias multiresistentes. Https://www.anvisa.gov.br/servicosaude/controle/reniss/manual%20_controle_bacterias.pdf
|
[31]
|
Agência Nacional de Vigilancia Sanitária (2013) Nota Técnica No 01/2013: Medidas de prevenção e controle de infecções por enterobactérias multiresistentes. https://cevs.rs.gov.br/upload/arquivos/201706/30132435-1369161512-nota-tec-01-2013-anvisa.pdf
|
[32]
|
Kiddee, A., Assawatheptawee, K., Naudom, A., Treebupachatsakul, P., Wangteeraprasert, A., Walsh, T.R., et al. (2018) Risk Factors for Gastrointestinal Colonization and Acquisition of Carbapenem-Resistant Gram-Negative Bacteria among Patients in Intensive Care Units in Thailand. Antimicrobial Agents and Chemotherapy, 62, e00341-18. https://doi.org/10.1128/AAC.00341-18
|
[33]
|
Segagni Lusignani, L., Starzengruber, P., Dosch, V., Assadian, O., Presterl, E. and Diab-Elschahawi, M. (2017) Molecular Epidemiology of Multidrug-Resistant Clinical Isolates of Acinetobacter baumannii. Wiener klinische Wochenschrift, 129, 816-822. https://doi.org/10.1007/s00508-017-1242-7
|
[34]
|
Tischendorf, J., de Avila, R.A. and Safdar, N. (2016) Risk of Infection Following Colonization with Carbapenem-Resistant Enterobacteriaceae: A Systematic Review. American Journal of Infection Control, 44, 539-543. https://doi.org/10.1016/j.ajic.2015.12.005
|
[35]
|
Vincent, J.-L., Rello, J., Marshall, J., Silva, E., Anzueto, A., Martin, C.D., et al. (2009) International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. JAMA, 302, 2323-2329. https://doi.org/10.1001/jama.2009.1754
|
[36]
|
Vincent, J.L., Bihari, D.J., Suter, P.M., Bruining, H.A., White, J., Nicolas-Chanoin, M.H., et al. (1995) The Prevalence of Nosocomial Infection in Intensive Care Units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. JAMA, 274, 639-644. https://doi.org/10.1001/jama.1995.03530080055041
|
[37]
|
Vázquez-López, R., Solano-Gálvez, S.G., Juárez Vignon-Whaley, J.J., Abello Vaamonde, J.A., Padró Alonzo, L.A., Rivera Reséndiz, A., et al. (2020) Acinetobacter baumannii Resistance: A Real Challenge for Clinicians. Antibiotics, 9, Article No. 205. https://doi.org/10.3390/antibiotics9040205
|
[38]
|
Palacios-Baena, Z.R., Giannella, M., Manissero, D., Rodríguez-Baño, J., Viale, P., Lopes, S., et al. (2020) Risk Factors for Carbapenem-Resistant Gram-Negative Bacterial Infections: A Systematic Review. Clinical Microbiology and Infection, 27, 228-235. https://doi.org/10.1016/j.cmi.2020.10.016
|
[39]
|
Vincent, J.-L., Sakr, Y., Singer, M., Martin-Loeches, I., Machado, F.R., Marshall, J.C., et al. (2020) Prevalence and Outcomes of Infection among Patients in Intensive Care Units in 2017. JAMA, 323, 1478-1487. https://doi.org/10.1001/jama.2020.2717
|
[40]
|
Uwingabiye, J., Lemnouer, A., Baidoo, S., Frikh, M., Kasouati, J., Maleb, A., et al. (2017) Intensive Care Unit-Acquired Acinetobacter baumannii Infections in a Moroccan Teaching Hospital: Epidemiology, Risk Factors, and Outcome. Germs, 7, 193-205. https://doi.org/10.18683/germs.2017.1126
|
[41]
|
Kumar, S., Sen, P., Gaind, R., Verma, P.K., Gupta, P., Suri, P.R., et al. (2018) Prospective Surveillance of Device-Associated Health Care-Associated Infection in an Intensive Care Unit of a Tertiary Care Hospital in New Delhi, India. American Journal of Infection Control, 46, 202-206. https://doi.org/10.1016/j.ajic.2017.08.037
|
[42]
|
Parajuli, N.P., Acharya, S.P., Dahal, S., Singh, J.P., Mishra, S.K., Kattel, H.P., et al. (2017) Epidemiology of Device-Associated Infections in an Intensive Care Unit of a Teaching Hospital in Nepal: A Prospective Surveillance Study from a Developing Country. American Journal of Infection Control, 45, 1024-1029. https://doi.org/10.1016/j.ajic.2017.02.040
|
[43]
|
Qiao, F., Huang, W., Gao, S., Cai, L., Zhu, S., Wei, L., et al. (2020) Risk Factor for Intestinal Carriage of Carbapenem-Resistant Acinetobacter baumannii and the Impact on Subsequent Infection among Patients in an Intensive Care Unit: An Observational Study. BMJ Open, 10, Article ID: e035893. https://doi.org/10.1136/bmjopen-2019-035893
|
[44]
|
Ramirez, M.S., Bonomo, R.A. and Tolmasky, M.E. (2020) Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace. Biomolecules, 10, Article No. 720. https://doi.org/10.3390/biom10050720
|
[45]
|
Avila-Novoa, M.-G., Solís-Velázquez, O.-A., Rangel-López, D.-E., González-Gómez, J.-P., Guerrero-Medina, P.-J. and Gutiérrez-Lomelí, M. (2019) Biofilm Formation and Detection of Fluoroquinolone- and Carbapenem-Resistant Genes in Multidrug-Resistant Acinetobacter baumannii. Canadian Journal of Infectious Diseases and Medical Microbiology, 2019, Article ID: 3454907. https://doi.org/10.1155/2019/3454907
|
[46]
|
Smani, Y., McConnell, M.J. and Pachón, J. (2012) Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells. PLoS ONE, 7, Article ID: e33073. https://doi.org/10.1371/journal.pone.0033073
|
[47]
|
Eze, E.C., Chenia, H.Y. and Zowalaty, M.E. (2018) Acinetobacter baumannii Biofilms: Effects of Physicochemical Factors, Virulence, Antibiotic Resistance Determinants, Gene Regulation, and Future Antimicrobial Treatments. Infection and Drug Resistance, 11, 2277-2299. https://doi.org/10.2147/IDR.S169894
|
[48]
|
Ryu, S.Y., Baek, W.-K. and Kim, H.A. (2017) Association of Biofilm Production with Colonization among Clinical Isolates of Acinetobacter baumannii. The Korean Journal of Internal Medicine, 32, 345-351. https://doi.org/10.3904/kjim.2015.287
|
[49]
|
Gaid, E., Assiri, A., McNabb, S. and Banjar W. (2018) Device-Associated Nosocomial Infection in General Hospitals, Kingdom of Saudi Arabia, 2013-2016. Journal of Epidemiology and Global Health, 7, S35-S40. https://doi.org/10.1016/j.jegh.2017.10.008
|
[50]
|
Ling, M.L., Apisarnthanarak, A. and Madriaga, G. (2015) The Burden of Healthcare-Associated Infections in Southeast Asia: A Systematic Literature Review and Meta-Analysis. Clinical Infectious Diseases, 60, 1690-1699. https://doi.org/10.1093/cid/civ095
|
[51]
|
Kołpa, M., Wałaszek, M., Gniadek, A., Wolak, Z. and Dobroś W. (2018) Incidence, Micro-Biological Profile and Risk Factors of Healthcare-Associated Infections in Intensive Care Units: A 10 Year Observation in a Provincial Hospital in Southern Poland. International Journal of Environmental Research and Public Health, 15, Article No. 112. https://doi.org/10.3390/ijerph15010112
|
[52]
|
Giannella, R.A., Broitman, S.A. and Zamcheck, N. (1972) Gastric Acid Barrier to Ingested Microorganisms in Man: Studies in Vivo and in Vitro. Gut, 13, 251-256. https://doi.org/10.1136/gut.13.4.251
|
[53]
|
Willems, R.P.J., van Dijk, K., Ket, J.C.F. and Vandenbroucke-Grauls, C.M.J.E. (2020) Evaluation of the Association between Gastric Acid Suppression and Risk of Intestinal Colonization with Multidrug-Resistant Microorganisms. JAMA Internal Medicine, 180, 561-571. https://doi.org/10.1001/jamainternmed.2020.0009
|
[54]
|
Huizinga, P., van den Bergh MK, van Rijen, M., Willemsen, I., van‘t Veer, N. and Kluytmans J. (2017) Proton Pump Inhibitor Use Is Associated with Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae Rectal Carriage at Hospital Admission: A Cross-Sectional Study. Clinical Infectious Diseases, 64, 361-363. https://doi.org/10.1093/cid/ciw743
|
[55]
|
Donskey, C.J. (2004) The Role of the Intestinal Tract as a Reservoir and Source for Transmission of Nosocomial Pathogens. Clinical Infectious Diseases, 39, 219-226. https://doi.org/10.1086/422002
|